The role of antiresorptive therapies in improving patient care in early and metastatic breast cancer Dulcinea Candelaria-QuintanaZoneddy R. DayaoMelanie E. Royce Review 11 October 2011 Pages: 355 - 363
A systematic review of breast cancer incidence risk prediction models with meta-analysis of their performance Catherine MeadsIkhlaaq AhmedRichard D. Riley Review 22 October 2011 Pages: 365 - 377
Prediction of BRCA2-association in hereditary breast carcinomas using array-CGH Simon A. JoosseKim I. M. BrandwijkPetra M. Nederlof Preclinical study 08 July 2010 Pages: 379 - 389
KX-01, a novel Src kinase inhibitor directed toward the peptide substrate site, synergizes with tamoxifen in estrogen receptor α positive breast cancer Muralidharan AnbalaganLatonya CarrierBrian G. Rowan Preclinical study 21 April 2011 Pages: 391 - 409
Estrogen receptor-α and sex steroid hormones regulate Toll-like receptor-9 expression and invasive function in human breast cancer cells Jouko SandholmJoonas H. KauppilaKatri S. Selander Preclinical study 24 May 2011 Pages: 411 - 419
Prevalence and characterization of BRCA1 and BRCA2 germline mutations in Chinese women with familial breast cancer Juan ZhangRenguang PeiYuntao Xie Preclinical Study 26 May 2011 Pages: 421 - 428
Increased risk for distant metastasis in patients with familial early-stage breast cancer and high EZH2 expression Sharon Hensley AlfordKatherine ToyCelina G. Kleer Preclinical Study 26 May 2011 Pages: 429 - 437
Gene expression profiling assigns CHEK2 1100delC breast cancers to the luminal intrinsic subtypes Jord H. A. NagelJustine K. PeetersHanne Meijers-Heijboer Preclinical Study 26 May 2011 Pages: 439 - 448
The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells Hagai LigumskyIdo WolfTami Rubinek Preclinical Study 03 June 2011 Pages: 449 - 461
In situ detection of HER2:HER2 and HER2:HER3 protein–protein interactions demonstrates prognostic significance in early breast cancer Melanie SpearsKaren J. TaylorJohn M. S. Bartlett Preclinical Study 03 June 2011 Pages: 463 - 470
Bone metastasis in a novel breast cancer mouse model containing human breast and human bone Tian-Song XiaGuo-Zhu WangShui Wang Preclinical Study 03 June 2011 Pages: 471 - 486
Pilot and feasibility study: prospective proteomic profiling of mammary epithelial cells from high-risk women provides evidence of activation of pro-survival pathways Catherine Ibarra-DrendallMichelle M. TrochVictoria L. Seewaldt Preclinical study 07 June 2011 Pages: 487 - 498
A prognostic model for lymph node-negative breast cancer patients based on the integration of proliferation and immunity Ensel OhYoon-La ChoiYoung Kee Shin Preclinical Study 11 June 2011 Pages: 499 - 509
ER, HER2, and TOP2A expression in primary tumor, synchronous axillary nodes, and asynchronous metastases in breast cancer Jeanette Dupont JensenAnn KnoopAnne-Vibeke Laenkholm Preclinical study 11 June 2011 Pages: 511 - 521
Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapse J. Chuck HarrellAleix PratCharles M. Perou Preclinical Study Open access 14 June 2011 Pages: 523 - 535
LMTK3 expression in breast cancer: association with tumor phenotype and clinical outcome Justin StebbingAleksandra FilipovicGeorgios Giamas Preclinical Study 14 June 2011 Pages: 537 - 544
The prognostic significance of B lymphocytes in invasive carcinoma of the breast S. M. A. MahmoudA. H. S. LeeA. R. Green Preclinical Study 14 June 2011 Pages: 545 - 553
The anatomy of fluid-yielding ducts in breast cancer Dominique TwelvesAshutosh NerurkarGerald P. H. Gui Preclinical study 15 June 2011 Pages: 555 - 564
Metabotropic glutamate receptor-1: a potential therapeutic target for the treatment of breast cancer Cecilia L. SpeyerJennifer S. SmithDavid H. Gorski Preclinical Study 17 June 2011 Pages: 565 - 573
Targeting low molecular weight cyclin E (LMW-E) in breast cancer Angela Nanos-WebbNatalie A. JabbourKhandan Keyomarsi Preclinical Study 22 June 2011 Pages: 575 - 588
Phase II trial of preoperative paclitaxel, gemcitabine, and trastuzumab combination therapy in HER2 positive stage II/III breast cancer: The Korean Cancer Study Group BR 07-01 Seock-Ah ImKeun Seok LeeSung Whan Ha Clinical trial 18 November 2011 Pages: 589 - 600
Comparison of two nomograms to predict pathologic complete responses to neoadjuvant chemotherapy for breast cancer: evidence that HER2-positive tumors need specific predictors Albane FratiElisabeth ChereauRoman Rouzier Clinical Trial 09 December 2011 Pages: 601 - 607
Postoperative dose-dense sequential versus concomitant administration of epirubicin and paclitaxel in patients with node-positive breast cancer: 5-year results of the Hellenic Cooperative Oncology Group HE 10/00 phase III Trial Helen GogasUrania DafniGeorge Fountzilas Clinical trial 21 December 2011 Pages: 609 - 619
Absence of ectopic epithelial inclusions in 3,904 axillary lymph nodes examined in sentinel technique Sonja IkenMarcus SchmidtStephan C. Schaefer Clinical Trial 22 December 2011 Pages: 621 - 624
Effect of baseline serum vitamin D levels on aromatase inhibitors induced musculoskeletal symptoms: results from the IBIS-II, chemoprevention study using anastrozole Shalini SinghJack CuzickAnthony Howell Clinical trial 25 December 2011 Pages: 625 - 629
Outcomes of a weight loss intervention among rural breast cancer survivors Christie A. BefortJennifer R. KlempCarol J. Fabian Clinical trial 25 December 2011 Pages: 631 - 639
Cadherin–catenin complex dissociation in lobular neoplasia of the breast Mary MorroghVictor P. AndradeTari A. King Epidemiology 13 November 2011 Pages: 641 - 652
Breast epithelial cell proliferation is markedly increased with short-term high levels of endogenous estrogen secondary to controlled ovarian hyperstimulation Karine ChungLinda J. Hovanessian-LarsenCeleste Leigh Pearce Epidemiology Open access 15 November 2011 Pages: 653 - 660
Serum enterolactone levels and mortality outcome in women with early breast cancer: a retrospective cohort study Pamela GuglielminiAlessandra RubagottiFrancesco Boccardo Epidemiology 18 November 2011 Pages: 661 - 668
Phenocopy breast cancer rates in Israeli BRCA1 BRCA2 mutation carrier families: is the risk increased in non-carriers? Shiri BernholtzYael LaitmanEitan Friedman Epidemiology 24 November 2011 Pages: 669 - 673
Surgical treatment of early stage breast cancer in elderly: an international comparison M. KiderlenE. BastiaannetG. J. Liefers Epidemiology Open access 27 November 2011 Pages: 675 - 682
Vitamin D intake, vitamin D receptor polymorphisms, and breast cancer risk among women living in the southwestern U.S. Dana E. RollisonAshley L. ColeAnna R. Giuliano Epidemiology 01 December 2011 Pages: 683 - 691
Melatonin pathway genes and breast cancer risk among Chinese women Sandra L. DemingWei LuWei Zheng Epidemiology 03 December 2011 Pages: 693 - 699
Multilevel determinants of breast cancer survival: association with geographic remoteness and area-level socioeconomic disadvantage Paramita DasguptaPeter D. BaadeGavin Turrell Epidemiology 09 December 2011 Pages: 701 - 710
A genetic risk predictor for breast cancer using a combination of low-penetrance polymorphisms in a Japanese population Aiko SuetaHidemi ItoKeitaro Matsuo Epidemiology 11 December 2011 Pages: 711 - 721
Risk of breast cancer in families of multiple affected women and men Melanie BevierKristina SundquistKari Hemminki Epidemiology 17 December 2011 Pages: 723 - 728
Pre-diagnosis body mass index and survival after breast cancer in the After Breast Cancer Pooling Project Marilyn L. KwanWendy Y. ChenBette J. Caan Epidemiology 21 December 2011 Pages: 729 - 739
Genetic variants at chromosome 9p21, 10p15 and 10q22 and breast cancer susceptibility in a Chinese population Jiaping ChenYue JiangHongbing Shen Epidemiology 25 December 2011 Pages: 741 - 746
A cost-benefit analysis of bevacizumab in combination with paclitaxel in the first-line treatment of patients with metastatic breast cancer Alberto J. MonteroKiran AvanchaGilberto Lopes Brief Report 27 December 2011 Pages: 747 - 751
Optimal outcomes for liver-dominant metastatic breast cancer with transarterial chemoembolization with drug-eluting beads loaded with doxorubicin Robert C. G. MartinKen RobbinsRicardo Monaco Brief Report 27 December 2011 Pages: 753 - 763
Melatonin suppresses aromatase expression and activity in breast cancer associated fibroblasts Kevin C. KnowerSarah Q. ToColin D. Clyne Brief Report 12 January 2012 Pages: 765 - 771
